SecBot SecBot
SC 13G ·Filed Sep 16, 2026

NEPH

NEPHROS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago SEC0001398344-26-017126
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future conversion to a Schedule 13D, which would signal activist intent. The stake size is moderate and passive, so no near-term catalyst is expected.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
NEPH ▼ -17.02% at T+20d
NEUTRAL call -17.02% · α vs SPY -18.23% · entry $4.23 → $3.51
Next anchor: T+60d in 6w
Latest observation: T+26 -24.32% FF3 residual α
Entry = T+0 close
Sep 16, 2026
via day close
T+1d
+1.89%
call +1.89% · α +2.01%
$4.31
settled 6w ago
T+5d
-2.13%
call -2.13% · α -2.73%
$4.14
settled 5w ago
T+20d
-17.02%
call -17.02% · α -18.23%
$3.51
settled 13d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

Charles E. Davidson and CD Holding Company, LLC filed a Schedule 13G disclosing a 5.68% passive stake in Nephros Inc., representing 616,945 shares of common stock. The filing indicates no intent to influence or change control of the company, consistent with a passive investment.

Key Financial Metrics

Stake
5.68%
Investor
Charles E. Davidson and CD Holding Company, LLC

Key Facts

  • Charles E. Davidson and CD Holding Company, LLC filed a joint Schedule 13G on September 16, 2026.
  • The reporting persons beneficially own 616,945 shares of Nephros common stock.
  • The stake represents 5.68% of shares outstanding, based on 10,860,120 shares outstanding as of August 7, 2026.
  • The filing is made under Rule 13d-1(c), indicating passive investment intent with no control purpose.
  • Davidson is a controlling person of CD Holding Company, LLC and may be deemed to beneficially own the shares held by CD Holdings.

Financial Impact

Passive 5.68% stake with no immediate financial impact.

Risk Factors

  • Potential future conversion to 13D could signal activist pressure.
  • Insider selling or reduction of stake could indicate loss of confidence.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001398344-26-017126
Document: 0001398344-26-017126-index-headers.html0001398344-26-017126
Document: 0001398344-26-017126-index.html0001398344-26-017126
Document: 0001398344-26-017126.txt0001398344-26-017126
9 reports for NEPH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NEPH — sortable, filterable
TypeNow
Oct 14, 2026
13d ago
DEF 14A
NEUTRAL ★ 5/10
$3.51awaiting T+20—$3.51 (−0.00%)
Oct 13, 2026
14d ago
8-K
NEUTRAL ★ 2/10
$3.52awaiting T+20—$3.51 (−0.28%)
Sep 16, 2026
5w ago
SC 13D/A
BEARISH ★ 6/10
$4.23 $3.51▲ +17.02%▲ +18.23%$3.51 (+17.02%)
Sep 16, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$4.23 $3.51▼ −17.02%▼ −18.23%$3.51 (−17.02%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$4.21 $4.06▼ −3.56%▼ −3.17%$3.51 (−16.63%)
May 7, 2026
24w ago
8-K
MIXED ★ 5/10
$3.52 $3.42▼ −2.84%▼ −2.86%$3.51 (−0.28%)
Apr 30, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$3.11 $3.69▲ +18.65%▲ +13.38%$3.51 (+12.86%)
Mar 12, 2026
32w ago
Press Release
MIXED ★ 6/10
$3.50 $2.91▼ −16.86%▼ −20.45%$3.51 (+0.29%)
Mar 5, 2026
33w ago
Press Release
NEUTRAL ★ 3/10
$3.89 $2.87▼ −26.22%▼ −22.43%$3.51 (−9.77%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026